| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K79669418 |
| PharmacoGx | BRD-K79669418 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLA2G4F | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | POLD4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | GGTLC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | CD302 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | CGB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | CES1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | ABCB6 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | FSCN2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | PROC | CTRPv2 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | C4orf50 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
